Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Enfermedades Infecciosas Y Microbiologia Clinica|December 17, 2008
[Pharmacogenetics of antiretroviral therapy 2008: toward personalized treatment?]Francesc Vidal MarsalExpert Opinion on Pharmacotherapy|March 26, 2011
Combination antiretroviral therapyPere Domingo, Francesc VidalHepatology (Baltimore, Md.)|January 28, 2006
Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?Elias Zintzaras, Ioannis Stefanidis, Mauro Santos, et al.Expert Opinion on Drug Safety|June 29, 2016
Switching antiretroviral regimes for the treatment of HIV: safety implicationsLaia Utrillo, Francesc Vidal, Teresa Puig, et al.Expert Opinion on Pharmacotherapy|May 19, 2016
Drug therapies for HIV-related metabolic disordersKaruna Lamarca, Ana García Sarasola, Francesc Vidal, et al.Expert Opinion on Pharmacotherapy|December 7, 2020
The pharmacological management of cardiovascular disease in people living with HIV (PLWH)Noemí Corbacho, Isabel Mur, Maria Ema Molas, et al.AIDS Reviews|September 29, 2018
Tolerability of Current Antiretroviral Single-Tablet RegimensPere Domingo, Mª Gracia Mateo, Mª Del Mar Gutierrez, et al.Expert Review of Clinical Pharmacology|April 25, 2019
Does choice of antiretroviral drugs matter for inflammation?María Del Mar Gutierrez, María Gracia Mateo, Francesc Vidal, et al.Expert Opinion on Pharmacotherapy|March 21, 2013
Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDSMa Gracia Mateo, Ma del Mar Gutierrez, Francesc Vidal, et al.Expert Opinion on Drug Safety|March 7, 2014
Drug safety profile of integrase strand transfer inhibitorsMaria del Mar Gutierrez, Maria Gracia Mateo, Francesc Vidal, et al.Pageof 12